Nucor Corp: Form 10-Q for the period ended Sep 30, 2023
Filed with the SEC on Nov 8, 2023 and accepted by EDGAR at Nov 8, 2023, 09:28 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-02 to 2023-09-30 | $8.78bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-01-01 to 2023-09-30 | $27.01bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-07-02 to 2023-09-30 | $6.85bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-01-01 to 2023-09-30 | $20.59bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2023-07-02 to 2023-09-30 | $385.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-01-01 to 2023-09-30 | $1.23bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2023-07-02 to 2023-09-30 | $63.2m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-01-01 to 2023-09-30 | $186.7m | us-gaap:InterestExpense |
| Income tax | 3 months2023-07-02 to 2023-09-30 | $326.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-01-01 to 2023-09-30 | $1.15bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-02 to 2023-09-30 | $1.14bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-01-01 to 2023-09-30 | $3.74bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-07-02 to 2023-09-30 | $4.57 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-01-01 to 2023-09-30 | $14.83 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-07-02 to 2023-09-30 | $4.58 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-01-01 to 2023-09-30 | $14.86 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-07-02 to 2023-09-30 | 248,916,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-01-01 to 2023-09-30 | 251,179,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-01-01 to 2023-09-30 | $5.59bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-01-01 to 2023-09-30 | $1.50bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2023-01-01 to 2023-09-30 | $388.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2023-01-01 to 2023-09-30 | $1.38bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-09-30 | $5.86bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-09-30 | $15.95bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-09-30 | $34.27bn | us-gaap:Assets |
| Current liabilities | At period end2023-09-30 | $4.28bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-09-30 | $12.76bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2023-09-30 | $35.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-09-30 | $20.47bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-09-30 | 245,838,999 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-23-060729. Last ingested by Listed: Oct 30, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.